[Corrections] Corrections

Reddy KR, Zeuzem S, Zoulim F, et al. Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial. Lancet Infect Dis 2015; 15: 27–35—The online appendix of this Article has been corrected as of March 21, 2016.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Tags: Corrections Source Type: research